Overview of Dr. Villaflor
Dr. Victoria Villaflor is an oncologist in Duarte, CA and is affiliated with City of Hope Comprehensive Cancer Center. She received her medical degree from Rush Medical College of Rush University Medical Center and has been in practice 22 years. She is one of 222 doctors at City of Hope Comprehensive Cancer Center who specialize in Oncology. She has more than 80 publications and over 500 citings.
Office
1500 E. Duarte Road
Duarte, CA 91010
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004- Rush University Medical CenterResidency, Internal Medicine, 1998 - 2001
Rush Medical College of Rush University Medical CenterClass of 1998
Certifications & Licensure
CA State Medical License 2020 - 2026
IL State Medical License 1998 - 2026- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 346 citationsPhase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck CancerEzra E.W. Cohen, Theodore Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan
Journal of Clinical Oncology. 2014-09-01 - 38 citationsSalivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.Nicole A. Cipriani, Elizabeth A. Blair, Joshua H. Finkle, Jennifer L. Kraninger, Christopher M. Straus
International Journal of Surgical Pathology. 2017-05-12 - 3 citationsBETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors.Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor
Cancer Gene Therapy. 2024-04-01
Journal Articles
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerNisha Mohindra, Victoria Villaflor, Clinical Lung Cancer
Authored Content
- Association of Tumor Mutational Burden with DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small Cell Lung CancerSeptember 2018
Press Mentions
Radical Therapy for Stage III NSCLC: Practical Advice to ConsiderMay 7th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
